| Income Statement |
| Operating Expenses | 3.22M |
|
| Research and Development Expense | 1.89M |
| Selling, General and Administrative Expense | 1.33M |
| Operating Income | -3.22M |
| Net Income | -3.13M |
| Net Income Common Stock | -3.13M |
| Net Income Common Stock (USD) | -3.13M |
| Consolidated Income | -3.13M |
| Earnings per Basic Share | -0.62 |
| Earnings per Basic Share (USD) | -0.62 |
| Earnings per Diluted Share | -0.62 |
| Earning Before Interest & Taxes (EBIT) | -3.13M |
| Earning Before Interest & Taxes (USD) | -3.13M |
| Weighted Average Shares | 5.02M |
| Weighted Average Shares Diluted | 5.02M |
| Balance Sheet |
| Cash and Equivalents | 8.81M |
| Cash and Equivalents (USD) | 8.81M |
| Current Assets | 9.30M |
| Property, Plant & Equipment Net | 318.47K |
| Total Assets | 9.62M |
| Current Liabilities | 7.57M |
| Total Liabilities | 23.64M |
| Accumulated Retained Earnings (Deficit) | -162.55M |
| Accumulated Other Comprehensive Income | -699.89K |
| Shareholders Equity | -14.03M |
| Shareholders Equity (USD) | -14.03M |
| Assets Non-Current | 318.47K |
| Liabilities Non-Current | 16.07M |
| Trade and Non-Trade Payables | 19.99M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 36.06K |
| Net Cash Flow from Financing | 1.37M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -718.70K |
| Issuance (Purchase) of Equity Shares | 1.37M |
| Net Cash Flow from Operations | -2.08M |
| Effect of Exchange Rate Changes on Cash | -2.04K |
| Share Based Compensation | 422.20K |